WALL STREET ASSOCIATES - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 59 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WALL STREET ASSOCIATES ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q1 2016$288,000
-86.0%
274,600
-60.6%
0.12%
-79.2%
Q4 2015$2,054,000
-6.6%
696,3000.0%0.58%
+37.3%
Q3 2015$2,200,000
-69.4%
696,300
-42.7%
0.42%
-37.9%
Q2 2015$7,195,000
-45.6%
1,215,400
-1.7%
0.68%
-45.7%
Q1 2015$13,224,000
+11.8%
1,237,000
-1.8%
1.25%
+10.1%
Q4 2014$11,827,000
+32.6%
1,259,500
+8.4%
1.13%
+23.1%
Q3 2014$8,922,000
-18.9%
1,161,700
-5.2%
0.92%
-2.5%
Q2 2014$11,000,0001,225,0000.94%
Other shareholders

There were no reported owners of PERNIX THERAPEUTICS HLDGS IN in Q2 2016.

NameSharesValueWeighting ↓
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders